BACK
Project/Company Name
Provectus Therapeutics Limited
Project Leader
Source of Funding/Programme
TSSSU
Description
identify potential drug resistance within patients' tumor to predict the personalised cancer treatment, by implmenting properitary AI analytic system, state-of-the-art microfluidics technologies and single cell analysis.
Project/Company Name
Provectus Therapeutics Limited
Project Leader
Source of Funding/Programme
TSSSU
Description
identify potential drug resistance within patients' tumor to predict the personalised cancer treatment, by implmenting properitary AI analytic system, state-of-the-art microfluidics technologies and single cell analysis.
Logo
Starting Year
2024
Business Area
Biotech
Nature
TSSSU Company